Andere Sprachen Venus Remedies Limited NSE India S.E.

Aktien

A40C1B

INE411B01019

VENUSREM

Markt geschlossen - NSE India S.E. Andere Börsenplätze 13:43:53 28.05.2024			% 5 Tage	% 1. Jan.
297.3 ^INR	+0.05%		-2.52%	-26.82%

19.03.	Venus Remedies erhält Zulassungen in der Ukraine für drei Onkologie-Medikamente	MT
08.03.	Venus Remedies erhält ukrainische Marktzulassung für drei Onkologieprodukte	MT

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Venus Remedies Secures Marketing Authorizations in Ukraine for Three Oncology Drugs	19.03.
Venus Remedies Gets Ukraine's Marketing Approval for Three Oncology Products	08.03.
Venus Remedies Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	14.02.
Venus Remedies Gets Ukraine Marketing Approval for Chemotherapy Drug, Antibiotics	13.02.
Venus Remedies Gets Marketing Authorization in Malta for Two Chemotherapy Drugs	12.01.
Venus Remedies Gets Authorization to Market Cancer Drugs in Israel, Colombia	21.12.
Indian Equities Clock Sharp Losses on Wednesday Due to Widespread Selling	20.12.
Venus Remedies Expands Into Wellness Business	20.12.
Venus Remedies Gets Bahrain Marketing Authorization for Enoxaparin	19.12.
Indian Equities Score Another Record Highs on Tuesday, Lifted by Ruling Party's State Polls Win	05.12.
Venus Remedies Gets Azerbaijan's Marketing Approval for Blood Clot Prevention Drug	05.12.
Venus Remedies Gets Marketing Approval for Cancer Drugs in Philippines, Saudi Arabia	01.12.
Venus Remedies Limited Receives Market Authorizations in Saudi Arabia and Philippines	01.12.
Venus Remedies' Consolidated Profit Jumps in Fiscal Q2	27.11.
Venus Remedies Arm Gets Authorization to Market Cancer Drug in UK	26.10.23
Venus Remedies Secures Marketing Approval for Six Key Chemotherapy Drugs in Philippines	16.10.23
Venus Remedies Limited Receives Marketing Approval from the Philippines for Six Key Chemotherapy Drugs	16.10.23
Venus Remedies Launches Antibiotic Elores in Ecuador	12.10.23
Venus Remedies Limited Expands Global Reach with the Launch of Elores in Ecuador	12.10.23
Venus Remedies Gets Marketing Authorization from Serbia for Chemotherapy Drugs	20.09.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Venus Remedies Limited NSE India S.E.

Aktien

A40C1B

INE411B01019

VENUSREM

Andere Sprachen

Filter